Phase 2a Study News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Phase 2a Study. Real-time updates on events, politics, business and more.

VDA-1102 Demonstrates Favorable Activity in Mycosis Fungoides

January 29, 2024

VDA-1102 led to an objective response rate of 56% in patients with mycosis fungoides, according to findings from an interim analysis of a phase 2a study.

Eteläuomen Läi Max Herzberg Vidac Pharma Emmilia Hodak Ministry Of Health Rabin Center Beilinson Hospital

Source: onclive.com

Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and Obesity

May 27, 2023

Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and Obesity.

Source: medindia.net

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Phase 2a Study News Today

VDA-1102 Demonstrates Favorable Activity in Mycosis Fungoides

Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and Obesity

Explore More Categories